Search Result

Results for "

LET

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Apoptosis (2) Bacterial (2) Bcl-2 Family (2) Biochemical Assay Reagents (1) Caspase (2) Drug Isomer (1) MicroRNA (94) Molecular Glues (3) Parasite (2) Reference Standards (2) TGF-beta/Smad (2)
By Research Areas:	Cancer (77) Infection (4) Inflammation/Immunology (2) Metabolic Disease (2) Neurological Disease (1)
Oligonucleotides:	miRNA mimics (24) miRNA antagomirs (20) miRNA agomirs (20) MicroRNAs (84) miRNA inhibitors (20)

Inhibitors & Agonists

Natural
Products

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-112659

*Lin28-let-7 antagonist 1*	MicroRNA	Neurological Disease Cancer
Lin28-let-7 antagonist 1 (compound 1632) is a potent antagonist of *Lin28/pre-let-7 interaction. Lin28-let-7* antagonist 1 inhibits Lin28A binding to pre-let-7a-2, with an IC₅₀ of 8 μM. Lin28-let-7 antagonist 1 inhibits proliferation in human cancer cells .

HY-123905

LIN28 inhibitor LI71	MicroRNA Parasite	Infection Cancer
LIN28 inhibitor LI71 is a LIN28 inhibitor that effectively inhibits LIN28:let-7 binding (IC₅₀: 7 μM). LIN28 inhibitor LI71 can abolish LIN28-mediated oligouridylation of let-7 precursor (IC₅₀: 27 μM). LIN28 inhibitor LI71 has potential application value in LIN28-driven cancer research. LIN28 inhibitor LI71 inhibits the interaction of cold shock protein of Plasmodium falciparum (PfCoSP) with DNA and α/β tubulin and has an inhibitory effect on Plasmodium falciparum .

HY-N6082

Rhein 8-O-β-D-Glucopyranoside 1 Publications Verification	Apoptosis Bcl-2 Family Caspase TGF-beta/Smad Bacterial	Infection Metabolic Disease Inflammation/Immunology
Rhein 8-O-β-D-Glucopyranoside is an orally active glycoside found in Rhubarb. Rhein 8-O-β-D-Glucopyranoside attenuates high glucose-induced apoptosis, recovers altered lincRNA ANRIL and let-7a expression, reverses high glucose-altered Bcl-2 and cleaved caspase-3 protein expression, and inhibits TGF-β1/Smad signaling. Rhein 8-O-β-D-Glucopyranoside accelerates Sennoside A (HY-N0365) metabolism, stimulates sennoside A purgative activity. Rhein 8-O-β-D-Glucopyranoside inhibits bacterial biofilm formation, suppresses its virulence gene expression, and exerts antibacterial activity. Rhein 8-O-β-D-Glucopyranoside can be used for the research of diabetic nephropathy, constipation, and infection .

HY-R00003

*hsa-let-7a-5p mimic*	MicroRNA	Cancer
hsa-let-7a-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7a-5p mimic hsa-let-7a-5p mimic

HY-168437

LIN28-IN-2	MicroRNA	Cancer
LIN28-IN-2 is a Lin28 inhibitor with activity against Lin28a, Lin28b, and their zinc knuckle domain. LIN28-IN-2 blocks Lin28-RNA substrate binding, perturbs zinc knuckle domain conformation. LIN28-IN-2 inhibits cancer cell proliferation, spheroid growth, and induces G2/M phase arrest. LIN28-IN-2 suppresses cancer stem cell phenotypes, Lin28-mediated stress granule formation, let-7 target genes, cancer stem cell biomarkers, and neuroendocrine biomarkers expression in cancer cells. LIN28-IN-2 can be used for the research of cancer .

HY-R04633

*hsa-let-7d-5p mimic*	MicroRNA	Others
hsa-let-7d-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7d-5p mimic hsa-let-7d-5p mimic

HY-R00005

*hsa-let-7b-5p mimic*	MicroRNA	Cancer
hsa-let-7b-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7b-5p mimic hsa-let-7b-5p mimic

HY-RI00003

*hsa-let-7a-5p inhibitor*	MicroRNA	Cancer
hsa-let-7a-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-let-7a-5p inhibitor hsa-let-7a-5p inhibitor

HY-RI00005

*hsa-let-7b-5p inhibitor*	MicroRNA	Cancer
hsa-let-7b-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-let-7b-5p inhibitor hsa-let-7b-5p inhibitor

HY-R00002

*hsa-let-7a-3p mimic*	MicroRNA	Cancer
hsa-let-7a-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7a-3p mimic hsa-let-7a-3p mimic

HY-RI00001

*hsa-let-7a-2-3p inhibitor*	MicroRNA	Cancer
hsa-let-7a-2-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-let-7a-2-3p inhibitor hsa-let-7a-2-3p inhibitor

HY-R00007A

*hsa-let-7c-5p agomir*	MicroRNA
hsa-let-7c-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-let-7c-5p agomir hsa-let-7c-5p agomir

HY-RI00007A

*hsa-let-7c-5p antagomir*	MicroRNA	Cancer
hsa-let-7c-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-let-7c-5p antagomir hsa-let-7c-5p antagomir

HY-100692

*Lin28-let-7a antagonist 1* 2 Publications Verification	MicroRNA	Cancer
Lin28-let-7a antagonist 1 shows a clear antagonistic effect against the Lin28-let-7a interaction with an IC₅₀ of 4.03 μM for Lin28A-let-7a-1 interaction.

HY-177782

SB1349	Molecular Glues MicroRNA	Cancer
SB1349 is a molecular glucose degrading agent that targets the Lin28 protein. SB1349 can effectively induce proteasome dependent degradation of Lin28A and Lin28B. SB1349 can increase the level of mature let-7 miRNA, downregulate the oncogenes targeted by let-7, and effectively induce the differentiation of neuroblastoma cells. SB1349 can be used for cancer research .

HY-123905A

LIN28 inhibitor LI71 enantiomer	Drug Isomer MicroRNA Parasite	Infection Cancer
LIN28 inhibitor LI71 enantiomer is the less active enantiomer of LIN28 inhibitor LI71 (HY-123905). LIN28 inhibitor LI71 is a LIN28 inhibitor that effectively inhibits LIN28:let-7 binding (IC₅₀: 7 μM). LIN28 inhibitor LI71 can abolish LIN28-mediated oligouridylation of let-7 precursor (IC₅₀: 27 μM). LIN28 inhibitor LI71 has potential application value in LIN28-driven cancer research. LIN28 inhibitor LI71 inhibits the interaction of cold shock protein of Plasmodium falciparum (PfCoSP) with DNA and α/β tubulin and has an inhibitory effect on Plasmodium falciparum .

HY-177731

MG-Lin1	Molecular Glues MicroRNA	Cancer
MG-Lin1 is a molecular glucose degrading agent that targets the Lin28 protein. MG-Lin1 can significantly reduce the mRNA levels of let-7 targeting oncogenes. MG-Lin1 can significantly inhibit the migration ability of cancer cells. MG-Lin1 has no obvious cytotoxicity. MG-Lin1 can be used for cancer research .

HY-177733

MG-Lin3	Molecular Glues MicroRNA	Cancer
Lin28 degrader MG-Lin3 is a molecular glucose degrading agent that targets the Lin28 protein. Lin28 degrader MG-Lin3 significantly reduces the Renilla luciferase signal at 100 µM. Lin28 degrader MG-Lin3 inhibits the maturation of tumor microRNA let-7. Lin28 degrader MG-Lin3 can be used for cancer research .

HY-R02560

*mmu-let-7j mimic*	MicroRNA	Cancer
mmu-let-7j mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-let-7j mimic mmu-let-7j mimic

HY-R02561

*mmu-let-7k mimic*	MicroRNA	Cancer
mmu-let-7k mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-let-7k mimic mmu-let-7k mimic

HY-R00008

*hsa-let-7d-3p mimic*	MicroRNA	Cancer
hsa-let-7d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7d-3p mimic hsa-let-7d-3p mimic

HY-R00007

*hsa-let-7c-5p mimic*	MicroRNA	Cancer
hsa-let-7c-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7c-5p mimic hsa-let-7c-5p mimic

HY-R00014

*hsa-let-7i-5p mimic*	MicroRNA	Cancer
hsa-let-7i-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7i-5p mimic hsa-let-7i-5p mimic

HY-R00013

*hsa-let-7i-3p mimic*	MicroRNA	Cancer
hsa-let-7i-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7i-3p mimic hsa-let-7i-3p mimic

HY-R00004

*hsa-let-7b-3p mimic*	MicroRNA	Cancer
hsa-let-7b-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7b-3p mimic hsa-let-7b-3p mimic

HY-R00006

*hsa-let-7c-3p mimic*	MicroRNA	Cancer
hsa-let-7c-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7c-3p mimic hsa-let-7c-3p mimic

HY-R00009

*hsa-let-7e-3p mimic*	MicroRNA	Cancer
hsa-let-7e-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7e-3p mimic hsa-let-7e-3p mimic

HY-R00012

*hsa-let-7g-5p mimic*	MicroRNA	Cancer
hsa-let-7g-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7g-5p mimic hsa-let-7g-5p mimic

HY-RI02560

*mmu-let-7j inhibitor*	MicroRNA	Cancer
mmu-let-7j inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-let-7j inhibitor mmu-let-7j inhibitor

HY-R02558

*mmu-let-7a-2-3p mimic*	MicroRNA	Cancer
mmu-let-7a-2-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-let-7a-2-3p mimic mmu-let-7a-2-3p mimic

HY-R02557

*mmu-let-7a-1-3p mimic*	MicroRNA	Cancer
mmu-let-7a-1-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-let-7a-1-3p mimic mmu-let-7a-1-3p mimic

HY-R00001

*hsa-let-7a-2-3p mimic*	MicroRNA	Cancer
hsa-let-7a-2-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7a-2-3p mimic hsa-let-7a-2-3p mimic

HY-R02559

*mmu-let-7f-2-3p mimic*	MicroRNA	Cancer
mmu-let-7f-2-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-let-7f-2-3p mimic mmu-let-7f-2-3p mimic

HY-R00010

*hsa-let-7f-1-3p mimic*	MicroRNA	Cancer
hsa-let-7f-1-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7f-1-3p mimic hsa-let-7f-1-3p mimic

HY-R00011

*hsa-let-7f-2-3p mimic*	MicroRNA	Cancer
hsa-let-7f-2-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-let-7f-2-3p mimic hsa-let-7f-2-3p mimic

HY-RI00014

*hsa-let-7i-5p inhibitor*	MicroRNA	Cancer
hsa-let-7i-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-let-7i-5p inhibitor hsa-let-7i-5p inhibitor

HY-RI00006

*hsa-let-7c-3p inhibitor*	MicroRNA	Cancer
hsa-let-7c-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-let-7c-3p inhibitor hsa-let-7c-3p inhibitor

HY-RI00007

*hsa-let-7c-5p inhibitor*	MicroRNA	Cancer
hsa-let-7c-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-let-7c-5p inhibitor hsa-let-7c-5p inhibitor

HY-RI02557

*mmu-let-7a-1-3p inhibitor*	MicroRNA	Cancer
mmu-let-7a-1-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-let-7a-1-3p inhibitor mmu-let-7a-1-3p inhibitor

HY-RI02560A

*mmu-let-7j antagomir*	MicroRNA	Cancer
mmu-let-7j antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-let-7j antagomir mmu-let-7j antagomir

HY-RI02561A

*mmu-let-7k antagomir*	MicroRNA	Cancer
mmu-let-7k antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-let-7k antagomir mmu-let-7k antagomir

HY-R00008A

*hsa-let-7d-3p agomir*	MicroRNA
hsa-let-7d-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-let-7d-3p agomir hsa-let-7d-3p agomir

HY-R00002A

*hsa-let-7a-3p agomir*	MicroRNA
hsa-let-7a-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-let-7a-3p agomir hsa-let-7a-3p agomir

HY-R00005A

*hsa-let-7b-5p agomir*	MicroRNA
hsa-let-7b-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-let-7b-5p agomir hsa-let-7b-5p agomir

HY-R00012A

*hsa-let-7g-5p agomir*	MicroRNA
hsa-let-7g-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-let-7g-5p agomir hsa-let-7g-5p agomir

HY-R00006A

*hsa-let-7c-3p agomir*	MicroRNA
hsa-let-7c-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-let-7c-3p agomir hsa-let-7c-3p agomir

HY-R00003A

*hsa-let-7a-5p agomir*	MicroRNA
hsa-let-7a-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-let-7a-5p agomir hsa-let-7a-5p agomir

HY-R00001A

*hsa-let-7a-2-3p agomir*	MicroRNA
hsa-let-7a-2-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-let-7a-2-3p agomir hsa-let-7a-2-3p agomir

HY-R02558A

*mmu-let-7a-2-3p agomir*	MicroRNA	Cancer
mmu-let-7a-2-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-let-7a-2-3p agomir mmu-let-7a-2-3p agomir

HY-R04205A

*rno-let-7f-1-3p agomir*	MicroRNA	Cancer
rno-let-7f-1-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-let-7f-1-3p agomir rno-let-7f-1-3p agomir

Cat. No.	Product Name	Category	Target	Chemical Structure